UY27824A1 - Nueva formulación para la administración parenteral de crobenetina. - Google Patents

Nueva formulación para la administración parenteral de crobenetina.

Info

Publication number
UY27824A1
UY27824A1 UY27824A UY27824A UY27824A1 UY 27824 A1 UY27824 A1 UY 27824A1 UY 27824 A UY27824 A UY 27824A UY 27824 A UY27824 A UY 27824A UY 27824 A1 UY27824 A1 UY 27824A1
Authority
UY
Uruguay
Prior art keywords
parenteral administration
crobenetine
new formulation
new
formulation
Prior art date
Application number
UY27824A
Other languages
English (en)
Inventor
Dr Bernd Kruss
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27824A1 publication Critical patent/UY27824A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a una nueva formulación que contiene crobenetina o una de sus sales farmacéuticamente aceptables, para administración por vía parenteral.
UY27824A 2002-05-29 2003-05-27 Nueva formulación para la administración parenteral de crobenetina. UY27824A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10223784A DE10223784A1 (de) 2002-05-29 2002-05-29 Neue Formulierung zur parenteralen Applikation von Crobenetine

Publications (1)

Publication Number Publication Date
UY27824A1 true UY27824A1 (es) 2003-12-31

Family

ID=29432394

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27824A UY27824A1 (es) 2002-05-29 2003-05-27 Nueva formulación para la administración parenteral de crobenetina.

Country Status (10)

Country Link
EP (1) EP1511487A1 (es)
JP (1) JP2005531573A (es)
AR (1) AR040135A1 (es)
AU (1) AU2003240699A1 (es)
CA (1) CA2487153A1 (es)
DE (1) DE10223784A1 (es)
PE (1) PE20040067A1 (es)
TW (1) TW200406205A (es)
UY (1) UY27824A1 (es)
WO (1) WO2003099280A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers

Also Published As

Publication number Publication date
AU2003240699A1 (en) 2003-12-12
EP1511487A1 (de) 2005-03-09
JP2005531573A (ja) 2005-10-20
TW200406205A (en) 2004-05-01
PE20040067A1 (es) 2004-03-30
CA2487153A1 (en) 2003-12-04
AR040135A1 (es) 2005-03-16
WO2003099280A1 (de) 2003-12-04
DE10223784A1 (de) 2003-12-11

Similar Documents

Publication Publication Date Title
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
HN2003000407A (es) Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos.
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
UY28348A1 (es) Compuestos novedosos
ECSP055786A (es) Derivados de ciclohexano espirocíclicos
HN2006019066A (es) "(s)-n-metilnaltrexona"
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
ECSP045221A (es) Sales de valsartan
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
HN2004000109A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
NO20064808L (no) Orale matrixformuleringer med licarbazepin
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
CR7648A (es) Microcapsulas para la liberacion retardada y controlada del perindropil
ECSP066292A (es) Sistemas semi-sólidos que contienen derivados de azetidina
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
UY27620A1 (es) Ambroxoll para el tratamiento de dolores crónicos
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
ECSP034708A (es) Nueva sal de benzoilguanidina
UY27823A1 (es) Nueva formulación para la administración parenteral de un bloqueante del canal del na
GT199800008A (es) Procedimiento para la preparacion de un derivado de tetrahidropiridina.
CL2003002077A1 (es) Uso de una composicion farmaceutica que comprende un inhibidor de la recaptacion de norepinefrina seleccionado entre maprotilina, norpramina, desipramina, nisoxetina, atomoxetina, amoxapina, dexepina, lofepramina, amitriptilina, entre otros, para tra
HN1999000128A (es) Nuevos usos farmaceuticos para inhibidores nos.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150223